Patent details

92672 Product Name: Fluralaner ou un de ses sels

Basic Information

Publication number:
92672
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP057205395
Legal Status:
Active
Application number:
92672
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/2/13/158 Bravecto - Fluralaner
Marketing Authorization Type:
Marketing Authorization Date:
13/02/2014
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
03/03/2015
First Marketing Authorization date:
13/02/2014
Grant date:
02/11/2015
Activation date:
04/03/2025
Publication date:
02/11/2015
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
13/02/2029
SPC Extension Expiration:
13/02/2029
Rejection date:
Withdrawal date:

Owner

From:
03/03/2015
 
 

Name:
Nissan Chemical Industries Ltd.
Address:
7-1, Kanda Nishiki-cho 3-chome, Chiyoda-ku, Tokyo 101-0054, Japan (JP)

Agent

Name:
ARONOVA S.A.
From:
03/03/2015
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
KOMODA Mitsuaki, Nissan Chemical Industries, Ltd.
Address:
Japan (JP)

2

Name:
KIKUCHI Takamasa, Nissan Chemical Industries, Ltd
Address:
Japan (JP)

3

Name:
YAOSAKA Manabu, Nissan Chemical Industries, Ltd.
Address:
Japan (JP)

4

Name:
MIZUKOSHI Takashi, Nissan Chemical Industries Ltd
Address:
Japan (JP)

5

Name:
MITA Takeshi, Nissan Chemical Industries, Ltd.
Address:
Japan (JP)

Publication

Bulletin

Bulletin Heading:
SPC3
Bulletin edition number:
2025/05
Publication date:
07/04/2025
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:
31/03/2026
Annual Fee Number:
22
Annual Fee Amount:
420 Euro
Expected Payer:
Last Annual Fee Payment Date:
27/02/2025
Last Annual Fee Paid Number:
21
Last Annual Fee Paid Amount:
410 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages